ALPS Advisors’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-4,618
Closed -$1.13M 1105
2022
Q3
$1.13M Sell
4,618
-685
-13% -$185K 0.01% 434
2022
Q2
$1.31M Sell
5,303
-228
-4% -$61.5K 0.01% 408
2022
Q1
$1.83M Sell
5,531
-2,169
-28% -$668K 0.02% 226
2021
Q4
$2.77M Buy
7,700
+988
+15% +$334K 0.03% 208
2021
Q3
$2.19M Sell
6,712
-1,903
-22% -$645K 0.02% 305
2021
Q2
$2.69M Buy
8,615
+684
+9% +$210K 0.02% 240
2021
Q1
$2.53M Buy
7,931
+1,699
+27% +$544K 0.02% 242
2020
Q4
$2.02M Buy
6,232
+1,928
+45% +$533K 0.02% 276
2020
Q3
$1.19M Buy
4,304
+705
+20% +$203K 0.02% 327
2020
Q2
$869K Sell
3,599
-1,192
-25% -$239K 0.01% 350
2020
Q1
$695K Buy
4,791
+560
+13% +$93K 0.01% 370
2019
Q4
$722K Buy
4,231
+549
+15% +$102K 0.01% 452
2019
Q3
$655K Sell
3,682
-237
-6% -$51.2K 0.01% 433
2019
Q2
$1.02M Buy
3,919
+1,026
+35% +$272K 0.01% 326
2019
Q1
$826K Buy
2,893
+316
+12% +$105K 0.01% 372
2018
Q4
$838K Sell
2,577
-25
-1% -$8.68K 0.01% 343
2018
Q3
$1.17M Sell
2,602
-196
-7% -$77.3K 0.01% 346
2018
Q2
$1.15M Buy
2,798
+2
+0.1% +$725 0.01% 308
2018
Q1
$814K Sell
2,796
-1,406
-33% -$356K 0.01% 354
2017
Q4
$787K Buy
4,202
+166
+4% +$31K 0.01% 305
2017
Q3
$680K Buy
+4,036
New +$610K ﹤0.01% 313
2017
Q1
Sell
-3,528
Closed -$398K 856
2016
Q4
$398K Sell
3,528
-66
-2% -$7.65K ﹤0.01% 595
2016
Q3
$462K Buy
+3,594
New +$430K ﹤0.01% 311
2016
Q1
Sell
-4,986
Closed -$450K 782
2015
Q4
$450K Hold
4,986
﹤0.01% 545
2015
Q3
$4.63K Buy
+4,986
New +$439K ﹤0.01% 540

Other funds holding ABMD

ALPS Advisors's ABMD Position: Q4 2022 in Review

ALPS Advisors sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 4,618 shares — an estimated $1.13M sold.

ALPS Advisors first reported a position in ABMD in Q3 2015 and held it in 25 quarters. The position peaked at $2.77M in Q4 2021. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • ALPS Advisors reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • ALPS Advisors sold 4,618 Abiomed Inc shares in Q4 2022, an estimated $1.13M.
  • ALPS Advisors first reported a position in Abiomed Inc in Q3 2015 and held it in 25 quarters.
  • ALPS Advisors's Abiomed Inc position peaked at $2.77M in Q4 2021.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on ALPS Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.